Chimeric VLPs presenting the anti-tumour antigens were described for antigens such as: MUC1, survivin [24], HER-2 [25], carcinoembryonic antigen (CEA) [26], Prostate Specific Antigen (PSA) and more [27–29]. The gene discussed is MUC1; the disease is neoplasm.